India to Philippines: Metformin Export Trade Route
India has recorded 476 verified shipments of Metformin exported to Philippines, representing a combined trade value of $20.8M USD. This corridor is served by 52 active Indian exporters, with an average shipment value of $43.6K USD. The leading Indian exporter is INVENTIA HEALTHCARE LIMITED , which accounts for 39% of total export value with 91 shipments worth $8.2M USD. On the buying side, I.E. MEDICA INC is the largest importer in Philippines with $7.8M USD in purchases. The top 3 suppliers — INVENTIA HEALTHCARE LIMITED , FREDUN PHARMACEUTICALS LTD, INVENTIA HEALTHCARE LIMITED — together control 67% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Metformin corridor is one of India's established pharmaceutical export routes, with 476 shipments documented worth a combined $20.8M USD. The route is dominated by INVENTIA HEALTHCARE LIMITED , which alone accounts for roughly 39% of all export value, reflecting the consolidated nature of India's metformin manufacturing sector.
Across 52 active suppliers, the average shipment value stands at $43.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with metformin's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #5 among India's top metformin export destinations globally.
On the import side, key buyers of Indian metformin in Philippines include I.E. MEDICA INC , AMB HK ENTERPRISES INC, NELPA LIFESCIENCES INC and 75 others. I.E. MEDICA INC is the single largest importer with 84 shipments valued at $7.8M USD.
